For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Biopharmaceutical fermentation system refers to a biopharmaceutical equipment, it can be divided into fermenters, bioprocess analyzers, process monitoring devices, culture & media preparation.
Scope of the Report:
This report focuses on the Biopharmaceutical Fermentation Systems in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
In terms of application, the recombinant proteins segment held a major market share in 2017. High reliance on microbial systems for recombinant protein production contributed toward the leading share of the segment. Increase in investment in research activities and introduction of new protein therapeutics have significantly contributed to the development of recombinant therapeutic antibodies and proteins.
The worldwide market for Biopharmaceutical Fermentation Systems is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- GE Healthcare
- Thermo Fisher Scientific
- Danaher Corporation
- Sartorius StedimBiotech
- Nova Biomedicals
- Dickinson and Company
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Bioprocess Analyzers
- Process Monitoring Devices
- Culture & Media Preparation
- Culture Media, Buffers & Inducers
Market Segment by Applications, can be divided into
- Biopharmaceutical Companies
- Contract Manufacturing Organizations
- Contract Research Organizations
- Academic Research Institutes
- Food Industry
There are 15 Chapters to deeply display the global Biopharmaceutical Fermentation Systems market.
Chapter 1, to describe Biopharmaceutical Fermentation Systems Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Biopharmaceutical Fermentation Systems, with sales, revenue, and price of Biopharmaceutical Fermentation Systems, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Biopharmaceutical Fermentation Systems, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Biopharmaceutical Fermentation Systems market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Biopharmaceutical Fermentation Systems sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source